April 14, 2021
Health News

Fluvoxamine: Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant – 60 Minutes – CBS News

The race to find vaccines for COVID-19 has dominated the headlines, but there’s been less news about how to keep people with COVID out of the hospital. Tonight, we’re going to tell you a story about one possible treatment. It’s called fluvoxamine. The generic drug was developed 40 years ago as an antidepressant and has been primarily used to treat obsessive-compulsive disorder. Now, a small but ingenious clinical trial and a series of coincidences have led scientists to look closely at fluvoxamine…

Click here to view the original article.

Related Posts

You might also like ...

Article feature image
Study finds 1 in 3 COVID-19 survivors have neurological or mental health disorders – FirstCoastNews.com WTLV-WJXX
Article feature image
Wearing masks could save at least 14000 people from COVID-19 deaths by August, model predicts – KSL.com
Article feature image
For many sufferers of lingering COVID-19 symptoms, proving they are sick is a big part of the battle – KCCI Des Moines